Cell Pathways Inc, a tiny US company based in Pennsylvania, recently claimed that it is conducting human trials of a novel drug that can prevent and treat cancer by forcing tumour cells to commit suicide. The company also said that it will soon receive European and US patents for its drug, Prevatac, which it is currently testing to prevent a rare form of colon cancer that is inherited. Colon cancer is one of the major causes of cancer-related deaths in the US. The company is hopeful that drug might also be useful against the more common forms of cancer. The nine-year-old and rather obscure pharmaceutical company is also testing the drug to prevent recurrence of prostate and breast cancers, said a spokesperson for the company.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.